These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 38750370

  • 1. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J, Xu G, Guo G, Zhang H, Shang L.
    J Cancer Res Clin Oncol; 2024 May 15; 150(5):255. PubMed ID: 38750370
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predictive value of inflammation and nutritional index in immunotherapy for stage IV non-small cell lung cancer and model construction.
    Lei W, Wang W, Qin S, Yao W.
    Sci Rep; 2024 Jul 30; 14(1):17511. PubMed ID: 39080372
    [Abstract] [Full Text] [Related]

  • 6. PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients.
    Zeng R, Liu F, Fang C, Yang J, Luo L, Yue P, Gao B, Dong Y, Xiang Y.
    Front Immunol; 2021 Jul 30; 12():724443. PubMed ID: 34777341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Women patients with small-cell lung cancer using immunotherapy in a real-world cohort achieved long-term survival.
    He Y, Kong L, Ji X, Zhuo M, An T, Jia B, Chi Y, Wang J, Zhao J, Li J, Yang X, Chen H, Zhai X, Tai Y, Ding L, Wang Z, Wang Y.
    Thorac Cancer; 2024 Aug 30; 15(23):1727-1738. PubMed ID: 38923348
    [Abstract] [Full Text] [Related]

  • 9. Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy.
    Cui Y, Chen Y, Zhao P, Li S, Cheng Y, Ren X.
    Clin Transl Oncol; 2024 Oct 30; 26(10):2522-2530. PubMed ID: 38662170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors.
    Chen X, Li Z, Zhou J, Wei Q, Wang X, Jiang R.
    PeerJ; 2022 Oct 30; 10():e14566. PubMed ID: 36540802
    [Abstract] [Full Text] [Related]

  • 12. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer.
    Sonehara K, Tateishi K, Komatsu M, Yamamoto H, Hanaoka M.
    Thorac Cancer; 2020 Jun 30; 11(6):1578-1586. PubMed ID: 32286017
    [Abstract] [Full Text] [Related]

  • 13. Risk stratification and overall survival prediction in extensive stage small cell lung cancer after chemotherapy with immunotherapy based on CT radiomics.
    Wang F, Chen W, Chen F, Lu J, Xu Y, Fang M, Jiang H.
    Sci Rep; 2024 Sep 30; 14(1):22659. PubMed ID: 39349536
    [Abstract] [Full Text] [Related]

  • 14. Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.
    Li L, Zhang Z, Hu Y.
    Medicine (Baltimore); 2021 Sep 10; 100(36):e27029. PubMed ID: 34516493
    [Abstract] [Full Text] [Related]

  • 15. Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.
    Huang LL, Hu XS, Wang Y, Li JL, Wang HY, Liu P, Xu JP, He XH, Hao XZ, Jiang PD, Liu YT, Luo J, Zhou SY, Wang JW, Yang JL, Qin Y, Yuan P, Lin L, Shi YK.
    Thorac Cancer; 2021 Jul 10; 12(13):1943-1951. PubMed ID: 33969619
    [Abstract] [Full Text] [Related]

  • 16. Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers.
    Li X, Tong L, Wang S, Yu J, Lu B, Wang Q, Hu M, Wu J, Yu J, Li B, Zhang T.
    BMC Med; 2024 Sep 11; 22(1):381. PubMed ID: 39256789
    [Abstract] [Full Text] [Related]

  • 17. [Construction of a nomogram model for predicting 2-year survival rate of small cell lung cancer based on more comprehensive variables].
    Wei LJ, Hou Q, Yao NN, Liang Y, Cao X, Sun BC, Li HW, Liu JT, Xu SM, Cao J.
    Zhonghua Yi Xue Za Zhi; 2022 May 10; 102(17):1283-1289. PubMed ID: 35488697
    [Abstract] [Full Text] [Related]

  • 18. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
    Wu Y, Yang J, Qiao X, Li Y, Zhao R, Lin T, Li X, Wang M.
    Front Oncol; 2023 May 10; 13():1041140. PubMed ID: 37007079
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
    Han J, Fu C, Li B.
    Radiat Oncol; 2021 Mar 04; 16(1):47. PubMed ID: 33663551
    [Abstract] [Full Text] [Related]

  • 20. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    Shan Q, Shi J, Wang X, Guo J, Han X, Wang Z, Wang H.
    BMC Cancer; 2021 May 29; 21(1):640. PubMed ID: 34051733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.